Why is Remus Pharma. falling/rising?

As of 04-Nov, Remus Pharmaceuticals Ltd is experiencing a price increase, with the current price at 812.50, reflecting a rise of 42.45 or 5.51%. The stock has shown strong performance today, outperforming its sector by 5.98%. Additionally, the stock's delivery volume has significantly increased by 164.55% compared to the 5-day average, indicating rising investor participation. In terms of returns, the stock has gained 23.91% over the past week, while it has increased by 11.23% over the past month. However, it is important to note that the stock is still down 34.93% year-to-date and 36.09% over the past year, suggesting a challenging longer-term trend.
In the broader market context, the Sensex has experienced a decline of 1.31% over the past week and an increase of 2.83% over the past month, indicating that while the market has been relatively stable, Remus Pharmaceuticals has significantly outperformed it in the short term. The stock's current performance contrasts with its year-to-date and one-year returns, which are notably negative compared to the Sensex's positive performance of 8.26% year-to-date and 6.68% over the past year. This divergence highlights the stock's recent recovery despite its longer-term struggles, suggesting that investor sentiment may be shifting positively in the short term.